Vimarsana
Biggest News Aggregation in the World

Page 3 - Reverse Phase Protein Array News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Reverse Phase Protein Array. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Reverse Phase Protein Array Today - Breaking & Trending Today

Theralink® Technologies Appoints Seasoned Commercial Leader, Faith Zaslavsky, as President & Chief Operating Officer for its Precision Oncology Company - Vimarsana News

Theralink® Technologies Appoints Seasoned Commercial Leader, Faith Zaslavsky, as President & Chief Operating Officer for its Precision Oncology Company

Published: December 6, 2022

/PRNewswire/ -- Theralink Technologies (OTC: THER) ("Theralink" or the "Company"), the only US precision oncology company with commercial RPPA technology that...

Source: prnewswire.com
Related Topics:
United StatesMick RuxinInterest In Reverse Phase Protein Array TechnologyWashington State UniversityTheralink Technologies IncNational SalesBusiness AdministrationCompany TheralinkSeasoned Genomics Commercial LeaderSpecial InterestReverse Phase Protein Array TechnologyLead TheralinkFaith ZaslavskyChief Operating OfficerMedical ServicesMedical AffairsEnterprise AccountsGeneral ManagerNational Sales DirectorRegional Sales DirectorRegional Managed Care DirectorRegional AreaAmerican SocietyBreast Surgeons FoundationWashington State
Theralink® Technologies Accepted to Present Two Posters at the Upcoming San Antonio Breast Cancer Symposium - Vimarsana News

Theralink® Technologies Accepted to Present Two Posters at the Upcoming San Antonio Breast Cancer Symposium

Published: December 1, 2022

/PRNewswire/ -- Theralink Technologies (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel quantitative protein and...

Source: prnewswire.com
Related Topics:
United StatesSan AntonioMick RuxinTheralink Technologies IncProgram NumberReverse Phase Protein ArraySan Antonio Breast Cancer SymposiumTheralink TechnologiesTheralink AssayAdvanced Breast CancerPoster PresentationNovel QuantitativeDetermining DynamicPrecision TherapySpecial SessionPhosphoprotein AssayTreatment SelectionRoutine Clinical PracticeProspective Observational StudyAdvance Breast CancerPoster Session
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares - Vimarsana News

Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares

Published: November 29, 2022

/PRNewswire/ -- Theralink Technologies, Inc. (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein-based assay...

Source: prnewswire.com
Related Topics:
United StatesExchange CommissionJoseph Gunnar CoTheralink Technologies IncTheralink TechnologiesSecurities ActReverse Phase Protein Array
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares - Vimarsana News

Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares

Published: November 29, 2022

/PRNewswire/ -- Theralink Technologies, Inc. (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein-based assay...

Source: prnewswire.com
Related Topics:
United StatesExchange CommissionJoseph Gunnar CoTheralink Technologies IncTheralink TechnologiesSecurities ActReverse Phase Protein Array
Theralink® Technologies Appoints Dr. Mattia Cremona as its Director of its Biopharma Laboratory - Vimarsana News

Theralink® Technologies Appoints Dr. Mattia Cremona as its Director of its Biopharma Laboratory

Published: November 7, 2022

/PRNewswire/ -- Theralink Technologies, Inc. (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein-based assay...

Source: prnewswire.com
Related Topics:
United StatesUnited KingdomMick RuxinMattia CremonaBiopharma LaboratoryTheralink Technologies IncGeorge Mason UniversitySeasoned Cancer ResearchPhase Protein Array TechnologyRoyal College Of SurgeonsSeasoned Cancer Research FellowReverse Phase Protein Array TechnologyTheralink TechnologiesResearch FellowRoyal CollegeReverse Phase Protein ArrayBritish JournalMolecular Medicine